DNA methylation is associated with gene expression changes in sporadic Parkinson's disease in the PPMI cohort

被引：0
|
作者：
Gonzalez-Latapi, P.
Bustos, B.
Simuni, T.
Lubbe, S.
Krainc, D.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1081
引用
收藏
页码：S475 / S475
页数：1
相关论文
共 50 条
  • [31] Prevalence of homozygous deletions of the parkin gene in a cohort of patients with sporadic and familial Parkinson's disease
    Ujike, H
    Yamamoto, M
    Kanzaki, A
    Okumura, K
    Takaki, M
    Kuroda, S
    MOVEMENT DISORDERS, 2001, 16 (01) : 111 - 113
  • [32] Peripheral Blood Gene Expression and DNA Methylation Associated With Alzheimer' Disease Progression
    Narayan, Vaibhav
    Li, Ming
    Schultz, Timothy
    Sun, Yu
    Li, Qingqin
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 157 - 157
  • [33] Long-term Parkinson's disease progression in PIGD and TD subtypes in the PPMI cohort
    Aleksovski, D.
    Miljkovic, D.
    Antonini, A.
    MOVEMENT DISORDERS, 2017, 32
  • [34] Reference LINE-1 insertion polymorphisms correlate with Parkinson’s disease progression and differential transcript expression in the PPMI cohort
    Alexander Fröhlich
    Abigail L. Pfaff
    Vivien J. Bubb
    John P. Quinn
    Sulev Koks
    Scientific Reports, 13 (1)
  • [35] DNA methylation of the 5′-UTR DAT 1 gene in Parkinson's disease patients
    Rubino, Alfonso
    D'Addario, Claudio
    Di Bartolomeo, Martina
    Salamone, Enrico Michele
    Locuratolo, Nicoletta
    Fattapposta, Francesco
    Vanacore, Nicola
    Pascale, Esterina
    ACTA NEUROLOGICA SCANDINAVICA, 2020, 142 (03): : 275 - 280
  • [36] Non-motor features of p.A53T a-synuclein mutation carriers compared to sporadic Parkinson's disease in a PPMI cohort
    Stamelou, M.
    Koros, C.
    Simitsi, A.
    Beratis, I.
    Trapali, X. Geronicola
    Papadimitriou, D.
    Papagiannakis, N.
    Prentakis, A.
    Kontaxopoulou, D.
    Fragkiadaki, S.
    Antonelou, R.
    Papageorgiou, S.
    Stefanis, L.
    MOVEMENT DISORDERS, 2017, 32
  • [37] How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?
    Simuni, Tanya
    Caspell-Garcia, Chelsea
    Coffey, Christopher
    Lasch, Shirley
    Tanner, Caroline
    Marek, Ken
    PARKINSONISM & RELATED DISORDERS, 2016, 28 : 62 - 67
  • [38] Non-motor and neuropsychological features of p.A53T α-synuclein mutation carriers compared to sporadic Parkinson's disease in a PPMI cohort
    Koros, C.
    Stamelou, M.
    Simitsi, A. M.
    Beratis, I.
    Papadimitriou, D.
    Papagiannakis, N.
    Kontaxopoulou, D.
    Fragkiadaki, S.
    Trapali, X. Geronicola
    Prentakis, A.
    Antonelou, R.
    Bonakis, A.
    Papageorgiou, S. G.
    Stefanis, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 558 - 558
  • [39] DNA methylation changes associated with Parkinson's disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood
    Henderson-Smith, Adrienne
    Fisch, Kathleen M.
    Hua, Jianping
    Liu, Ganqiang
    Ricciardelli, Eugenia
    Jepsen, Kristen
    Huentelman, Mathew
    Stalberg, Gabriel
    Edland, Steven D.
    Scherzer, Clemens R.
    Dunckley, Travis
    Desplats, Paula
    EPIGENETICS, 2019, 14 (04) : 365 - 382
  • [40] Reference LINE-1 insertion polymorphisms correlate with Parkinson's disease progression and differential transcript expression in the PPMI cohort
    Frohlich, Alexander
    Pfaff, Abigail L.
    Bubb, Vivien J.
    Quinn, John P.
    Koks, Sulev
    SCIENTIFIC REPORTS, 2023, 13 (01):
12345